Change of principal share registrar and transfer office
Filed with HKEX · Stock code 1244 · · 1 page · English
Summary by 6ix AI
3D Medicines, Inc. has announced a change of its principal share registrar and transfer office. The new address for the principal share registrar in the Cayman Islands will be effective from a specified date in the future. Tricor Investor Services Limited will continue to serve as the branch share registrar in Hong Kong. The announcement is signed by Dr. Gong Zhaolong, Chairman of the Board.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from 3D Medicines
- Interim Report 2026
- Discloseable transaction
- 3D Medicines Inc Says Envafolimab Supplemental Application Accepted By NMPA
- 3D Medicines Inc Says Zhang Jing Resigns As CFO
- 3D Medicines Says New Drug Application For First-Line Treatment Of Biliary Tract Cancer Of Envafolimab Accepted
Later from 3D Medicines
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement latest progress in collaboration programs: achievement of pre-specified number of events in the global pivotal phase 3 REGAL trial for 3D189
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Follow 3D Medicines into a list and get an email when it puts out news.
Follow 3D Medicines